Drug Index


Mechanism :

Ambroxol is a mucolytic. It breaks down the acid mucopolysaccharide fibres which makes the sputum thinner and less viscous and therefore promotes mucus clearance. It also stimulates synthesis and release of surfactant by type II pneumocytes. The surfactant acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents. It also facilitates expectoration and eases productive cough. Ambroxol also has a mild anaesthetic effect and therefore used to relieve the pain in sire throat/Pharyngitis.

Indication :

  • Productive cough

Contraindications :


There are no other specific contraindications for administration of ambroxol however caution is advised in patients of gastric ulceration.

Dosing :

Children 2 to <6 years:
7.5-15 mg 3 times daily PO.
Children 6-12 years:
15-30 mg 2-3 times daily PO.
Children >12 years, Adolescents, Adults, and Elderly:
60-120 mg daily in 2-3 divided doses PO.

Adverse Effect :

Gastrointestinal disturbances, allergic reaction.

Hepatic Dose :

No dosage adjustments are recommended.
03/13/2024 05:46:29 Ambroxol
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0